retatrutide fat loss clinical trial results Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide Subcutaneous Fat Loss Results:

Mindy has been on a wellness journey for years, and its clearly paying off

In March 2026, topline results from the TRANSCEND-T2D-1 trials showed that participants with Type 2 diabetes achieved an average A1C reduction of up to 2.0% and lost nearly 17% of their body weight over 40 weeks

Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: a meta-analysis of randomized controlled trials

Here is what they contain, side by side with the doses that clinical studies actually used: The dosing gap is the core problem

GLP-1 stands for glucagon-like peptide-1, a hormone your body releases naturally after meals

This guide walks you through reconstitution, dose calculations, and a safe starting protocolwhether you have 5mg, 10mg, or 20mg vials